Metraipolis › archive › dc_fd470221f502

Engineering cuproptosis with nanomedicine: Design, combination therapy, and translation in cancer — Europe PMC PMID:42569284

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42569284
DOI
10.1016/j.mtbio.2026.103466
License (as archived)
solo-consultazione
Archived
2026-10-06T09:10:42.865Z
SHA-256 of the archived text
ad213dc74b1f4c7a0d80d0b78980c999f2aa0c10f8f0eb641d0401dec1650594
Stable URL of this page
https://metraipolis.com/documento/dc_fd470221f502

How to cite

Engineering cuproptosis with nanomedicine: Design, combination therapy, and translation in cancer — Europe PMC PMID:42569284 — Europe PMC (en), https://europepmc.org/article/MED/42569284 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd470221f502 (Metraipolis archive dc_fd470221f502, sha256 ad213dc74b1f4c7a0d80d0b78980c999f2aa0c10f8f0eb641d0401dec1650594)
BibTeX
@misc{dcfd470221f502,
  title = {Engineering cuproptosis with nanomedicine: Design, combination therapy, and translation in cancer — Europe PMC PMID:42569284},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42569284},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd470221f502; sha256 ad213dc74b1f4c7a0d80d0b78980c999f2aa0c10f8f0eb641d0401dec1650594},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42569284. Agents can read the archived copy with the MCP tool read_document.